Long- versus short-acting beta 2-agonists. Implications for drug therapy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed, 4 syntheses or guidelines pooled it.

1. Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid.The Cochrane database of systematic reviews · 2007
   Pooled it
2. Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2005
   Guideline
3. Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.The Cochrane database of systematic reviews · 2002
   Pooled it
4. National athletic trainers' association position statement: preventing sudden death in sports.Journal of athletic training
   Guideline
5. 2003 canadian asthma consensus guidelines executive summary.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2006
   Article
6. Pharmacological treatment in acute exacerbations of chronic obstructive pulmonary disease.Drugs & aging · 1998
   Review
7. Pharmacokinetic optimisation of asthma treatment.Clinical pharmacokinetics · 1994
   Review
8. National Athletic Trainers' Association position statement: management of asthma in athletes.Journal of athletic training
   Article

Corrections and comments

• Erratum issued

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as